Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Exelon
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Exelon 9.5mg/24hours transdermal patches
0411000E0BBAGAG
|
Exelon | Rivastigmine | Central Nervous System | 725 |
|
Exelon 4.6mg/24hours transdermal patches
0411000E0BBAFAF
|
Exelon | Rivastigmine | Central Nervous System | 451 |
|
Exelon 13.3mg/24hours transdermal patches
0411000E0BBAHAI
|
Exelon | Rivastigmine | Central Nervous System | 125 |
|
Exelon 1.5mg capsules
0411000E0BBAAAA
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 2mg/ml oral solution
0411000E0BBAEAE
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 3mg capsules
0411000E0BBABAB
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 4.5mg capsules
0411000E0BBACAC
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 6mg capsules
0411000E0BBADAD
|
Exelon | Rivastigmine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.